However, only the cg20462795 exhibited significantly survival patterns (Supplementary Figure 6D), depicting that ELOVL2 associated epigenetic metabolic axis could be a novel therapeutic target in RPLS. The gene discussed is ELOVL2; the disease is Posterior Leukoencephalopathy Syndrome.